Motherisk update: Hemophilia during pregnancy

Ran D. Goldman, Victor Blanchette, Gideon Koren

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Question. A patient in my clinic, who is 10 weeks into her first pregnancy and is a known carrier of hemophilia B, is considering the advantages and disadvantages of antenatal tests and is especially worried about a vaginal delivery that might cause bleeding. How should I manage her pregnancy.? Answer. Many female carriers of hemophilia were found to have lower-than-expected levels of plasma factors, which are thought to be due to X chromosome inactivation. Chorionic villous sampling is the preferred test to determine the sex of the fetus and whether a male infant is affected with hemophilia. Vaginal delivery is not contraindicated and has been proven during the last two decades to be as safe as cesarean section. Vacuum extraction should be avoided to minimize risk of intracranial hemolysis and severe cephalhematoma.

Original languageEnglish
Pages (from-to)1601-1603
Number of pages3
JournalCanadian Family Physician
Volume49
Issue numberDEC.
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Motherisk update: Hemophilia during pregnancy'. Together they form a unique fingerprint.

Cite this